XML 78 R47.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidating Financial Information (Condensed Consolidating Statement of Cash Flows) (Details) - USD ($)
$ in Millions
3 Months Ended
May 02, 2020
May 04, 2019
Cash flows from operating activities:    
Net income (loss) $ (3,581) $ 136
Impairment, restructuring and other costs 3,184 1
Equity in loss (earnings) of subsidiaries 0 0
Dividends received from subsidiaries 0 0
Depreciation and amortization 237 236
Gains on sale of real estate (16) (43)
Change in assets, liabilities and other items not separately identified 12 (368)
Net cash provided (used) by operating activities (164) (38)
Cash flows from investing activities:    
Purchase of property and equipment and capitalized software, net of dispositions (139) (230)
Other, net 26 (7)
Net cash used by investing activities (113) (237)
Cash flows from financing activities:    
Debt issued, net of debt repaid 1,496 (3)
Dividends paid (117) (116)
Issuance or common stock 0 6
Intercompany activity, net 0 0
Other, net (231) (45)
Net cash provided (used) by financing activities 1,148 (158)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 871 (433)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, beginning of period 731 1,248
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, end of period 1,602 815
Parent    
Cash flows from operating activities:    
Net income (loss) (3,581) 136
Impairment, restructuring and other costs 0 0
Equity in loss (earnings) of subsidiaries 3,582 (132)
Dividends received from subsidiaries 251 225
Depreciation and amortization 0 0
Gains on sale of real estate 0 0
Increase (Decrease) in Other Operating Assets and Liabilities, Net 353 (78)
Net cash provided (used) by operating activities (101) 307
Cash flows from investing activities:    
Purchase of property and equipment and capitalized software, net of dispositions 0 0
Other, net 0 0
Net cash used by investing activities 0 0
Cash flows from financing activities:    
Debt issued, net of debt repaid 0 0
Dividends paid (117) (116)
Issuance of common stock, net of common stock acquired   6
Intercompany activity, net 1,082 (700)
Other, net (117) (93)
Net cash provided (used) by financing activities 848 (903)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 747 (596)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, beginning of period 413 889
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, end of period 1,160 293
Subsidiary Issuer    
Cash flows from operating activities:    
Net income (loss) (3,650) (43)
Impairment, restructuring and other costs 2,722 0
Equity in loss (earnings) of subsidiaries 795 30
Dividends received from subsidiaries 0 0
Depreciation and amortization 77 85
Gains on sale of real estate 0 (24)
Increase (Decrease) in Other Operating Assets and Liabilities, Net (151) 118
Net cash provided (used) by operating activities 95 (70)
Cash flows from investing activities:    
Purchase of property and equipment and capitalized software, net of dispositions (34) (52)
Other, net 0 0
Net cash used by investing activities (34) (52)
Cash flows from financing activities:    
Debt issued, net of debt repaid 1,497 (3)
Dividends paid 0 0
Issuance of common stock, net of common stock acquired   0
Intercompany activity, net (1,529) 214
Other, net (68) 28
Net cash provided (used) by financing activities (100) 239
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect (39) 117
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, beginning of period 64 64
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, end of period 25 181
Other Subsidiaries    
Cash flows from operating activities:    
Net income (loss) (727) 145
Impairment, restructuring and other costs 462 1
Equity in loss (earnings) of subsidiaries 0 0
Dividends received from subsidiaries 0 0
Depreciation and amortization 160 151
Gains on sale of real estate (16) (19)
Increase (Decrease) in Other Operating Assets and Liabilities, Net (214) 328
Net cash provided (used) by operating activities 93 (50)
Cash flows from investing activities:    
Purchase of property and equipment and capitalized software, net of dispositions (105) (178)
Other, net 26 (7)
Net cash used by investing activities (79) (185)
Cash flows from financing activities:    
Debt issued, net of debt repaid (1) 0
Dividends paid (251) (225)
Issuance of common stock, net of common stock acquired   0
Intercompany activity, net 447 486
Other, net (46) 20
Net cash provided (used) by financing activities 149 281
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 163 46
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, beginning of period 254 295
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, end of period 417 341
Consolidating Adjustments    
Cash flows from operating activities:    
Net income (loss) 4,377 (102)
Impairment, restructuring and other costs 0 0
Equity in loss (earnings) of subsidiaries (4,377) 102
Dividends received from subsidiaries (251) (225)
Depreciation and amortization 0 0
Gains on sale of real estate 0 0
Increase (Decrease) in Other Operating Assets and Liabilities, Net 0 0
Net cash provided (used) by operating activities (251) (225)
Cash flows from investing activities:    
Purchase of property and equipment and capitalized software, net of dispositions 0 0
Other, net 0 0
Net cash used by investing activities 0 0
Cash flows from financing activities:    
Debt issued, net of debt repaid 0 0
Dividends paid 251 225
Issuance of common stock, net of common stock acquired   0
Intercompany activity, net 0 0
Other, net 0 0
Net cash provided (used) by financing activities 251 225
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 0 0
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, beginning of period 0 0
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, end of period $ 0 $ 0